ArticleScientific reports2025
Circular RNA circFat3 as a biomarker for construction of postmortem interval Estimation models in mouse brain tissues at multiple temperatures.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrated renal histopathology, RNA decay, and protein degradation signatures enhance post-mortem interval prediction using machine-learning models in a veterinary forensic rat model.Veterinary world · 2026Article
- Molecular biology research progress in post-mortem interval (PMI) estimation in forensic medicine.International journal of legal medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Circular RNAs (circRNAs) are conserved, abundant, stable, and specifically expressed in mammals. The postmortem interval (PMI) estimation is crucial in forensic medicine, particularly for case investigation and civil action. CircRNAs may serve as ideal PMI biomarkers. However, no research has explored PMI estimation in the brain using circRNAs. The total RNA, including circRNA, was sampled from mouse brain tissues at multiple temperatures (4℃, 25℃, and 35℃). The semi-quantitative reverse transcription (RT)-PCR and real-time quantitative PCR (RT-qPCR) were used to test the postmortem degradation levels at different PMIs. As a result, we found circFat3 is highly and specifically expressed in mouse brain tissue, with postmortem levels significantly correlated with PMI across multiple temperatures. In addition, mt-co1 and 28 S rRNA demonstrated stability under various temperature conditions, supporting their use as reliable reference genes for PMI models. Moreover, the error rates showed that the circFat3/28S rRNA model was more accurate at 4℃. The circFat3/mt-co1 and circFat3/28S rRNA models provided slightly better predictions for short-term and long-term PMI, respectively at 25℃, while the circFat3/mt-co1 model was more accurate at 35℃. The combined application of the two reference genes was beneficial primarily for long-term PMI estimation. Furthermore, the validation results confirmed that these models were more accurate for long-term PMI estimation. Thus, our mathematical models were constructed at multiple temperatures based on circFat3 and these two reference genes. Taken together, this is the first study to identify circRNA circFat3 as a novel biomarker that may serve as a complementary tool for PMI estimation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.